Biotech Peptides
$27.00- Price / mg
- $270.00
- Document access
- Public link
Free USPS Priority over $200; lower-order rate not stated
Three public US 100 mcg (0.1 mg) IGF-1 LR3 research-reagent listings kept separate from 1 mg products, with availability state, unit price, evidence route, and source date preserved.
Current answer. As of Jul 23, 2026, 1 confirmed in-stock listings run from $27.00 to $27.00, with a $27.00 median across the in-stock rows. All 3 seller pages remain visible below.
Free USPS Priority over $200; lower-order rate not stated
Free USPS Priority over $200; lower-order rate not stated
A list-price starting point, not a product-quality, safety, or seller recommendation.

List price, document access, and final landed cost answer different questions. This view keeps them separate instead of turning them into one seller score.
Free USPS Priority over $200; lower-order rate not stated
Open vendor evidence profile →COA, LC, and MS images. Access is public, but authenticity and custody are not established.
Inspect transparency record →This difference compares list prices only. It does not assign value to a report or include shipping.
Calculate landed cost →How to read it: The Biotech Peptides row is both the lowest confirmed in-stock list price and the lowest row with a public document route. Document visibility is not product verification.
Filter IGF-1 LR3 vendors by stock, price, and public documents →Rank rule. Price rank is availability-aware and stays fixed when you search or re-sort this view. Affiliate status never enters the calculation.
Compare two lowest in-stock rowsChecked July 28, 2026 at 4:47 PM UTC. Confirmed means the public source matched the published price and returned a reliable current availability signal. No row needs manual review. This does not verify vial contents or product quality.
Open source-check ledger| Price rank / supplier | 0.1 mg price | Price / mg | Public evidence | Shipping claim | Open listing |
|---|---|---|---|---|---|
01Biotech PeptidesLowest confirmed in-stock list priceIn stock | $27.00Source confirmed | $270.00 | COA, LC, and MS imagesAccess: Public link · Seller claim · Jul 23, 2026 | Free USPS Priority over $200; lower-order rate not stated | |
02Purgo LabsUnavailable lower list priceOut of stock | $24.99Source confirmed | $249.90 | Public batch-report routeAccess: Public link · Seller claim · Jul 23, 2026 | Live UPS rate; free UPS 3 Day Select over $250 | |
03Core PeptidesPrice shown; stock label absentStatus not stated | $28.00Source confirmed | $280.00 | Product evidence sectionAccess: Public link · Seller claim · Jul 23, 2026 | Free over $200; lower-order rate at checkout |
1 In-stock headline prices exclude unavailable listings, coupons, and checkout-only discounts.
2 A seller COA or report is labeled as a claim unless Peptide Local commissioned the sample and controlled custody.
How we read a certificate of analysis →How to verify the seller and access route →Start with how the document can be reached, then match it to this exact IGF-1 LR3 0.1 mg row. Access is useful evidence, but it does not prove authenticity, custody, vial contents, sterility, or suitability.
The exact 100 mcg page displayed a public list price and seller-hosted analytical images. Peptide Local did not establish sample custody, test independence, or correspondence to shipped material.
The public catalog showed the 0.1 mg starting price while the exact variation was marked out of stock when checked. The row is retained only as unavailable market context.
The exact 100 mcg page showed a public price and ordering control. A distinct stock statement was not captured, so the row remains availability-unconfirmed and cannot win the in-stock headline.
The free checker keeps compound identity, lot matching, dates, laboratory attribution, report verification, custody, purity, identity testing, instrument output, and quantity separate.
These canonical matchups open directly on the IGF-1 LR3 0.1 mg board. Price, stock, document access, source freshness, and shipping stay separate.
Biotech Peptides is the only row marked in stock.
Biotech Peptides is the only row marked in stock.
Neither row can set an available-price winner.
Pair selection prioritizes rows that are currently comparable, include the board low, or expose a meaningful document-access contrast. It is not a seller ranking.
PubChem maintains a live substance record for long-(Arg3) insulin-like growth factor I and lists IGF-1 LR3 among its synonyms. That identity record is not an FDA approval, clinical recommendation, or finding that a seller vial matches the named substance.
Read the PubChem substance record ↗Price, chemical identity, clinical evidence, approved-product status, and local supply are different questions. This map shows which source answers each one and leaves unresolved fields visible.
Evidence routes checked through Jul 23, 2026This record resolves a name to the US laboratory research catalog tracked by Peptide Local. It does not establish authorization, lawful supply, medical use, or availability in the selected destination.
Read the PubChem substance recordNational Library of Medicine, PubChem↗The price board can compare current list price, nominal size, availability, shipping language, and seller document access. It cannot establish identity, quantity, purity, sterility, legality, or fitness for use.
Inspect every price and source row1 currently confirmed in stock↓IGF-1 LR3 is outside Peptide Local's current 13-program trial-count snapshot. That means no local count is published here, not that the count is zero. Search the live registry, then inspect the intervention, status, population, and posted results for each record.
Search IGF-1 LR3 on ClinicalTrials.govLive official registry route, not a cached result count↗The global index joins this identity to official product and seller or supply routes in 22 content languages. Only 0 countries currently have a separate compound-specific status finding in this dataset.
Open the complete worldwide mapIdentity, product, seller, and supply checks stay separate↗The routes below are still useful, but they connect the identity to general official records. Missing compound-specific evidence is not a legal or availability conclusion.
No compound-specific United States finding is attached to this snapshot. The exact guide connects IGF-1 LR3 to official product and seller or supply checks. That absence is not evidence of approval, prohibition, legality, availability, or seller authority.
No compound-specific Canada finding is attached to this snapshot. The exact guide connects IGF-1 LR3 to official product and seller or supply checks. That absence is not evidence of approval, prohibition, legality, availability, or seller authority.
No compound-specific France finding is attached to this snapshot. The exact guide connects IGF-1 LR3 to official product and seller or supply checks. That absence is not evidence of approval, prohibition, legality, availability, or seller authority.
No compound-specific México finding is attached to this snapshot. The exact guide connects IGF-1 LR3 to official product and seller or supply checks. That absence is not evidence of approval, prohibition, legality, availability, or seller authority.
No compound-specific Australia finding is attached to this snapshot. The exact guide connects IGF-1 LR3 to official product and seller or supply checks. That absence is not evidence of approval, prohibition, legality, availability, or seller authority.
It can show the visible list price, normalized unit cost, availability label, delivery claim, document language, destination market, and date checked.
A seller page or uploaded certificate does not replace independent sampling, chain-of-custody evidence, regulatory authorization, or professional judgment.
Current exact-size answers for price, document access, shipping, and source checks. No seller is converted into a product-quality or safety recommendation.
As of Jul 23, 2026, the lowest confirmed in-stock public list price in Peptide Local's exact-size US research-market sample is $27.00 from Biotech Peptides. Shipping, tax, coupons, subscriptions, bundles, and checkout-only fees are not included.
1 confirmed in-stock row link to a public seller document route: Biotech Peptides. The lowest of those rows is Biotech Peptides at $27.00. Public access does not authenticate a report, establish custody, or prove the contents of a supplied vial.
No. The board compares public single-unit list prices for the same 0.1 mg nominal size. The current lowest row states: Free USPS Priority over $200; lower-order rate not stated. Use the landed-cost calculator before treating the list-price order as the final order cost.
Confirm the exact identity and nominal size, current availability, landed cost, seller identity, destination-market rules, document route, lot or batch matching, analytical method, and source date. A seller-labelled research listing is not an approved medicine and public price or document access does not establish identity, purity, quantity, sterility, safety, legality, or fitness for human use.
Start by matching the exact IGF-1 LR3 identity and 0.1 mg listing to a current lot or batch identifier. Then check analysis date, named laboratory, report verification route, sample custody, separate purity and identity methods, instrument output, and any measured quantity result. Peptide Local's free ten-field checker can organize those questions, but document completeness does not prove authenticity or the contents of a supplied vial.
These guides explain local verification and access routes. They do not relabel this US research-price board as local inventory or medical availability.